104 related articles for article (PubMed ID: 2517020)
1. Magnetic resonance imaging evaluation of learning difficulties and incoordination in neurofibromatosis.
Dunn DW; Roos KL
Neurofibromatosis; 1989; 2(1):1-5. PubMed ID: 2517020
[TBL] [Abstract][Full Text] [Related]
2. [Encephalic lesions in neurofibromatosis: clinical manifestations and typical magnetic resonance findings].
Magnaldi S; White RM; Bryan RN
Radiol Med; 1990 Dec; 80(6):796-807. PubMed ID: 2126389
[TBL] [Abstract][Full Text] [Related]
3. Learning problems in neurofibromatosis patients.
Stine SB; Adams WV
Clin Orthop Relat Res; 1989 Aug; (245):43-8. PubMed ID: 2502350
[TBL] [Abstract][Full Text] [Related]
4. [Neurofibromatosis in children. Our experience].
López-Pisón J; Cuadrado-Martín M; Boldova-Aguar MC; Muñoz-Mellado A; Cabrerizo de Diago R; Peña-Segura JL
Rev Neurol; 2003 Nov 1-15; 37(9):820-5. PubMed ID: 14606048
[TBL] [Abstract][Full Text] [Related]
5. Impact of neurofibromatosis type 1 on school performance.
Krab LC; Aarsen FK; de Goede-Bolder A; Catsman-Berrevoets CE; Arts WF; Moll HA; Elgersma Y
J Child Neurol; 2008 Sep; 23(9):1002-10. PubMed ID: 18827266
[TBL] [Abstract][Full Text] [Related]
6. Pilot study of a novel computerized task to assess spatial learning in children and adolescents with neurofibromatosis type 1.
Ullrich NJ; Ayr L; Leaffer E; Irons MB; Rey-Casserly C
J Child Neurol; 2010 Oct; 25(10):1195-202. PubMed ID: 20139412
[TBL] [Abstract][Full Text] [Related]
7. [Specific learning and cognitive deficits in neurofibromatosis type 1].
Mahajnah M; Zimmerman S; Weitz R
Harefuah; 2001 Apr; 140(4):334-6. PubMed ID: 11303400
[No Abstract] [Full Text] [Related]
8. Development of MRI T2 hyperintensities and cognitive functioning in patients with neurofibromatosis type 1.
Feldmann R; Schuierer G; Wessel A; Neveling N; Weglage J
Acta Paediatr; 2010 Nov; 99(11):1657-60. PubMed ID: 21039823
[TBL] [Abstract][Full Text] [Related]
9. Brain magnetic resonance imaging of siblings from families with two or more children with learning or intellectual disabilities and need for full-time special education.
Mannerkoski M; Heiskala H; Raininko R; Aberg L; Sarna S; Wirtavuori K; Autti T
Acta Radiol; 2009 May; 50(4):437-45. PubMed ID: 19267273
[TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis: implications for learning and behavior.
Eliason MJ
J Dev Behav Pediatr; 1986 Jun; 7(3):175-9. PubMed ID: 3088045
[TBL] [Abstract][Full Text] [Related]
11. Hydrocephalus in neurofibromatosis. Contribution of magnetic resonance imaging to its diagnosis, control and treatment.
Pou-Serradell A; Ugarte-Elola AC
Neurofibromatosis; 1989; 2(4):218-26. PubMed ID: 2517815
[TBL] [Abstract][Full Text] [Related]
12. MRI and nonverbal cognitive deficits in children with neurofibromatosis 1.
Bawden H; Dooley J; Buckley D; Camfield P; Gordon K; Riding M; Llewellyn G
J Clin Exp Neuropsychol; 1996 Dec; 18(6):784-92. PubMed ID: 9157104
[TBL] [Abstract][Full Text] [Related]
13. 'Moya' than meets the eye: neurofibromatosis type 1 associated with Moyamoya syndrome.
Tan RM; Chng SM; Seow WT; Wong J; Lim CC
Singapore Med J; 2008 Apr; 49(4):e107-9. PubMed ID: 18418511
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging and behavioral analysis of immature rats with kaolin-induced hydrocephalus: pre- and postshunting observations.
Del Bigio MR; Crook CR; Buist R
Exp Neurol; 1997 Nov; 148(1):256-64. PubMed ID: 9398467
[TBL] [Abstract][Full Text] [Related]
15. Brain morphometry, T2-weighted hyperintensities, and IQ in children with neurofibromatosis type 1.
Greenwood RS; Tupler LA; Whitt JK; Buu A; Dombeck CB; Harp AG; Payne ME; Eastwood JD; Krishnan KR; MacFall JR
Arch Neurol; 2005 Dec; 62(12):1904-8. PubMed ID: 16344348
[TBL] [Abstract][Full Text] [Related]
16. Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1.
Denckla MB; Hofman K; Mazzocco MM; Melhem E; Reiss AL; Bryan RN; Harris EL; Lee J; Cox CS; Schuerholz LJ
Am J Med Genet; 1996 Feb; 67(1):98-102. PubMed ID: 8678124
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of children with cerebral white matter abnormalities.
Kristjánsdóttir R; Uvebrant P; Wiklund LM
Eur J Paediatr Neurol; 2000; 4(1):17-26. PubMed ID: 10701100
[TBL] [Abstract][Full Text] [Related]
18. Neurological complications involving the central nervous system in neurofibromatosis type 1.
Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted MR of the brain: methodology and clinical application.
Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N
Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887
[TBL] [Abstract][Full Text] [Related]
20. A longitudinal magnetic resonance imaging study of the brain in survivors in childhood acute lymphoblastic leukemia.
Harila-Saari AH; Pääkkö EL; Vainionpää LK; Pyhtinen J; Lanning BM
Cancer; 1998 Dec; 83(12):2608-17. PubMed ID: 9874469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
